Table 1.
Descriptive analysis for sample size and variables related to biographic data, tobacco habit, site of lesion, and clinical staging and histopathological grading in different study groups
| S. No. | Variable | Study group | Frequency | Total | |||
|---|---|---|---|---|---|---|---|
| 1 | Sample size (n) Vari | Group A (control) Group B (leukoplakia) |
40 40 |
80 | |||
| variables related to biographic date | |||||||
| 2 | Age, expressed as mean ± SD | Group A Group B |
39.55 ± 9.106 45.20 ± 11.009 |
||||
| 3 | Gender, expressed as number (%) | Responses | |||||
| Male | Female | ||||||
| Group A | 30 (75) | 10 (25) | |||||
| Group B | 30 (75) | 10 (25) | |||||
| Variables related to tobacco habit | |||||||
| 4 | Duration of habit (years), expressed as mean ± SD | Group B | 20.80 ± 10.469 | ||||
| 5 | Frequency of habit (no. of times/day), expressed as mean ± SD | Group B | 7.85 ± 3.317 | ||||
| Variables related to site of lesion | |||||||
| 6 | Site of lesion, expressed as number (%) | Group B | Responses | ||||
| Buccal mucosa | Alveolus | Vestibule | Tongue | ||||
| 30 (75) | 2 (5) | 4 (10) | 4 (10) | ||||
| Variables related to clinical stages and histopathological grades of group B—leukoplakia | |||||||
| 7 | Clinical staging (OLEP stages), expressed as number (%) | Group B | Responses | ||||
| Stage I | Stage II | Stage II | Stage III | Stage IV | |||
| 8 | Histopathological grading—dysplasia, expressed as number (%) | Group B | Responses | ||||
| Mild | Moderate | Severe | |||||
| 10 (25) | 14 (35) | 16 (40) | |||||
OLEP = oral leukoplakia, SD = standard deviation